J Scott Moncrief

Title: J Scott Moncrief: Innovator in Gene Expression Technology

Introduction

J Scott Moncrief is a notable inventor based in Galveston, TX (US). He has made significant contributions to the field of biotechnology, particularly in the area of gene expression. His work focuses on the development of innovative methods for the expression of heterologous genes, which have important applications in vaccine production.

Latest Patents

Moncrief holds a patent for "Membrane expression of heterologous genes." This invention relates to nucleic acid segments that are useful in constructing expression vectors for the expression of heterologous polypeptides directed to specific areas of the host cell. Selected constructs direct the production of polypeptides to the outer membrane surface of the cell, while other constructs direct expression to the inner membrane or periplasm of the host cell. Transformed host cells are potentially useful for producing vaccines or immunogens elicited in response to antigens expressed on the outer membranes of the host cells. He has 1 patent to his name.

Career Highlights

Moncrief is affiliated with the University of Texas System, where he continues to advance research in biotechnology. His work has implications for the development of new therapeutic strategies and vaccine technologies.

Collaborations

Some of his notable coworkers include David W Niesel and Linda H Phillips, who have collaborated with him on various research projects.

Conclusion

J Scott Moncrief's innovative work in gene expression technology highlights the potential for advancements in vaccine production and therapeutic applications. His contributions to the field are significant and continue to influence biotechnological research.